Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors
El Eit, Rabab, Itani, Abdul Rahman, Nassar, Farah, Rasbieh, Nagham, Jabbour, Mark, Santina, Ahmad, Zaatari, Ghazi, Mahon, François‐Xavier, Bazarbachi, Ali, Nasr, RihabLanguage:
english
Journal:
Cancer
DOI:
10.1002/cncr.32130
Date:
April, 2019
File:
PDF, 419 KB
english, 2019